162 related articles for article (PubMed ID: 31965930)
1. Synthesis and In Vitro Anticancer Activity of 6-Ferrocenylpyrimidin-4(3H)-one Derivatives.
Grabovskiy SA; Muhammadiev RS; Valiullin LR; Raginov IS; Kabal'nova NN
Curr Org Synth; 2019; 16(1):160-164. PubMed ID: 31965930
[TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
5. Novel ferrocenylbisphosphonate hybrid compounds: Synthesis, characterization and potent activity against cancer cell lines.
Anusionwu CG; Aderibigbe BA; Adeyemi SA; Ubanako P; Oselusi SO; Choonara YE; Yangkou Mbianda X
Bioorg Med Chem; 2022 Mar; 58():116652. PubMed ID: 35180594
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Anticancer and Antibacterial Activity of Some Novel Pyrano[2,3-d]pyrimidinone Carbonitrile Derivatives.
Aremu OS; Gopaul K; Kadam P; Singh M; Mocktar C; Singh P; Koorbanally NA
Anticancer Agents Med Chem; 2017; 17(5):719-725. PubMed ID: 27528181
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological screening of new thiazolo[4,5-d]pyrimidine and dithiazolo[3,2-a:5',4'-e]pyrimidinone derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
Abd Elhameed AA; El-Gohary NS; El-Bendary ER; Shaaban MI; Bayomi SM
Bioorg Chem; 2018 Dec; 81():299-310. PubMed ID: 30172111
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives.
Plażuk D; Wieczorek A; Ciszewski WM; Kowalczyk K; Błauż A; Pawlędzio S; Makal A; Eurtivong C; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B
ChemMedChem; 2017 Nov; 12(22):1882-1892. PubMed ID: 28941201
[TBL] [Abstract][Full Text] [Related]
10. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
11. New pyrimidinone and fused pyrimidinone derivatives as potential anticancer chemotherapeutics.
Rashad AE; Shamroukh AH; Yousif NM; Salama MA; Ali HS; Ali MM; Mahmoud AE; El-Shahat M
Arch Pharm (Weinheim); 2012 Sep; 345(9):729-38. PubMed ID: 22674829
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives.
Chern JH; Shia KS; Chang CM; Lee CC; Lee YC; Tai CL; Lin YT; Chang CS; Tseng HY
Bioorg Med Chem Lett; 2004 Mar; 14(5):1169-72. PubMed ID: 14980658
[TBL] [Abstract][Full Text] [Related]
13. Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.
Bozorov K; Zhao JY; Elmuradov B; Pataer A; Aisa HA
Eur J Med Chem; 2015 Sep; 102():552-73. PubMed ID: 26312434
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, spectroscopic investigation, and DFT study of N,N'-disubstituted ferrocene-based thiourea complexes as potent anticancer agents.
Asghar F; Fatima S; Rana S; Badshah A; Butler IS; Tahir MN
Dalton Trans; 2018 Feb; 47(6):1868-1878. PubMed ID: 29337321
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents.
Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD
Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665
[TBL] [Abstract][Full Text] [Related]
16. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
Li L; Ma L; Sun J
Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Structural Characterization of a Novel Ferrocene Derivative and Preliminarily Anticancer Activity.
Yong J; Wu X; Liao J; Lu C; Liu X
Med Chem; 2016; 12(5):426-31. PubMed ID: 26558374
[TBL] [Abstract][Full Text] [Related]
18. Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[
Gad EM; Nafie MS; Eltamany EH; Hammad MSAG; Barakat A; Boraei ATA
Molecules; 2020 May; 25(11):. PubMed ID: 32481682
[TBL] [Abstract][Full Text] [Related]
19. Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity.
Sun A; Lin J; Pi C; Xu R; Cui X
Arch Pharm (Weinheim); 2016 Mar; 349(3):186-92. PubMed ID: 26841261
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
